| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.25B | 85.54B | 94.96B | 88.27B | 163.95B | 168.10B |
| Gross Profit | 103.25B | 85.54B | 94.96B | 80.06B | 163.95B | 168.10B |
| EBITDA | -85.92B | 17.04B | 3.28B | 1.85B | 10.38B | 10.25B |
| Net Income | 11.07B | 10.56B | 5.65B | -324.64M | 5.95B | 5.71B |
Balance Sheet | ||||||
| Total Assets | 516.45B | 508.35B | 459.73B | 424.73B | 499.80B | 453.58B |
| Cash, Cash Equivalents and Short-Term Investments | 169.69B | 158.31B | 10.30B | 10.97B | 18.74B | 10.22B |
| Total Debt | 13.99B | 13.97B | 15.43B | 17.96B | 27.46B | 27.79B |
| Total Liabilities | 399.66B | 395.68B | 357.55B | 327.24B | 397.71B | 350.68B |
| Stockholders Equity | 107.10B | 103.26B | 93.25B | 86.02B | 92.71B | 93.03B |
Cash Flow | ||||||
| Free Cash Flow | 14.99B | 9.91B | 15.86B | 11.31B | 9.12B | 32.34B |
| Operating Cash Flow | 15.45B | 10.35B | 16.29B | 11.71B | 9.56B | 33.24B |
| Investing Cash Flow | -4.27B | -18.56B | -14.83B | -6.80B | -15.57B | -47.34B |
| Financing Cash Flow | -5.93B | 4.62B | 999.20M | -12.20B | 14.01B | 7.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$58.64B | 7.94 | 9.76% | 5.22% | 8.20% | 42.29% | |
74 Outperform | $92.08B | 11.27 | 10.74% | 1.81% | 23.64% | 36.32% | |
71 Outperform | HK$74.76B | 6.26 | 11.12% | 3.22% | 2.54% | 17.80% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | HK$79.84B | 12.81 | 5.22% | 2.66% | 30.38% | 2.63% | |
58 Neutral | HK$28.04B | 18.65 | 6.00% | ― | -2.69% | -68.97% | |
57 Neutral | HK$13.15B | 16.53 | 7.22% | ― | 19.01% | 64.43% |
China Reinsurance (Group) Corporation has nominated Lyu Zhi as a non-executive director candidate for its fifth board session, with his appointment subject to shareholder approval and regulatory clearance from the National Financial Regulatory Administration. Lyu, a PhD holder, brings international engineering experience from Schlumberger and senior investment roles at China Investment Corporation and its affiliates, and currently sits on the boards of several Galaxy-branded financial institutions; he will enter into a service contract with China Re but will not receive director’s remuneration, underscoring his role as an external, independent-minded board member as the group moves to refresh its governance structure.
The most recent analyst rating on (HK:1508) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation has obtained approval from China’s National Financial Regulatory Administration for amendments to its Articles of Association, as passed at its first extraordinary general meeting of 2025, with the revised articles taking effect from the regulator’s approval date. A key governance change under the new Articles is the abolition of the Board of Supervisors, with its statutory oversight duties to be transferred to the audit committee of the board, leading to the simultaneous dissolution of the supervisors’ special committees and the departure of four supervisors, who leave without any stated disagreements. The move streamlines the group’s corporate governance framework in line with updated regulatory requirements and may concentrate oversight functions within the board’s audit committee, potentially affecting how shareholders and regulators interface with the company’s internal control and supervisory mechanisms.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation has secured shareholder approval at its second extraordinary general meeting of 2025 to donate special funds in support of follow-up work relating to the Tai Po fire disaster in Hong Kong. The special resolution was overwhelmingly backed, with more than two-thirds of votes in favour, full board attendance, and no voting restrictions or abstention requirements, underscoring strong governance and broad shareholder alignment around the company’s disaster-relief commitment.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation has reshuffled its top leadership, appointing long-serving executive director Ms. Zhu Xiaoyun as vice chairlady of the fifth session of the board, effective 31 December 2025, with a remuneration structure comprising basic salary, performance-based annual pay and tenure incentives subject to board and shareholder approval. The board has also named Ms. Zhu as president of the company, with her formal assumption of the role pending regulatory approval from the National Financial Regulatory Administration; in the interim she will act as the provisional person-in-charge assuming presidential duties, replacing Mr. Zhuang Qianzhi in that capacity, signaling continuity in management and potentially strengthening strategic execution under an internally promoted leader with deep organizational experience.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation has announced the convening of its second extraordinary general meeting (EGM) of 2025 to be held on December 31, 2025. The primary agenda is to consider and approve a special resolution for the donation of special funds to support the aftermath of the Tai Po fire disaster in Hong Kong. This initiative reflects the company’s commitment to corporate social responsibility and may enhance its reputation and stakeholder relations.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation announced the postponement of its second extraordinary general meeting (EGM) originally scheduled for December 23, 2025, to December 31, 2025, due to coordination of work arrangements. Consequently, the book closure period for confirming shareholder entitlements to attend the EGM has been extended to December 31, 2025. This change allows shareholders more time to register and participate in the meeting, potentially impacting shareholder engagement and decision-making processes.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation announced the redemption of RMB4.0 billion capital supplementary bonds by its subsidiary, China Property and Casualty Reinsurance Company Ltd. This strategic move, completed after regulatory filings, reflects the company’s proactive financial management and may enhance its market positioning by optimizing its capital structure.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation announced the approval of Mr. Zhuang Qianzhi as the chairman of the board by the National Financial Regulatory Administration. This approval marks a significant step in the company’s leadership structure, potentially impacting its strategic direction and operations, with Mr. Zhuang set to lead until the expiry of the term of the fifth session of the board.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation has announced the composition of its board of directors, which includes eight directors with designated roles and functions. The board has also established five specialized committees, each with specific responsibilities, indicating a structured approach to governance and strategic oversight. This announcement reflects the company’s commitment to maintaining robust governance practices, which is crucial for its operations and industry positioning.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation has announced the closure of its register of members in preparation for its second extraordinary general meeting (EGM) of 2025, scheduled for December 23, 2025. This closure will take place from December 18 to December 23, 2025, during which no share transfers will be processed. Shareholders listed on the register by December 23, 2025, will be eligible to attend and vote at the EGM. The meeting will address various resolutions, details of which will be communicated to shareholders in due course.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation announced the successful conclusion of its first extraordinary general meeting of 2025, where several key resolutions were passed. These included amendments to the Articles of Association, the Rules of Procedures for both the General Meeting and the Board of Directors, and the abolishment of the Board of Supervisors. The resolutions were overwhelmingly supported by shareholders, indicating strong backing for the company’s strategic changes. This meeting reflects the company’s ongoing efforts to streamline governance and enhance operational efficiency, potentially impacting its industry positioning and stakeholder relations positively.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation announced the successful issuance of RMB4.0 billion in capital supplementary bonds by its subsidiary, China Re P&C, in the National Interbank Bond Market. These ten-year fixed-rate bonds, with conditional redemption rights and varying coupon rates, aim to bolster the subsidiary’s capital, improve solvency, and support sustainable business growth.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation has announced its first extraordinary general meeting (EGM) of 2025, scheduled for November 28th in Beijing. The meeting will address several key resolutions, including amendments to the Articles of Association and the Rules of Procedures, as well as the abolishment of the Board of Supervisors. Additionally, the meeting will cover the remuneration of directors and supervisors for the year 2023. The announcement reflects the company’s ongoing efforts to streamline its governance structure and enhance operational efficiency, potentially impacting its strategic direction and stakeholder engagement.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation has announced the proposed abolishment of its Board of Supervisors, with the functions and powers being transferred to the audit committee of the Board. This change is subject to approval at the shareholders’ general meeting and aims to streamline corporate governance in line with regulatory requirements, potentially impacting the company’s operational oversight and stakeholder engagement.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.
China Reinsurance (Group) Corporation has announced the closure of its register of members to confirm shareholder entitlements for its first extraordinary general meeting of 2025, scheduled for November 28. This closure, from November 25 to November 28, 2025, will affect share transfers, and shareholders are required to ensure their registration by November 24 to participate and vote at the meeting.
The most recent analyst rating on (HK:1508) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on China Reinsurance (Group) Corp. Class H stock, see the HK:1508 Stock Forecast page.